Avoro Capital Advisors LLC 13D/13G Filings for Aerpio Pharmaceuticals, Inc. (ARPO)

Avoro Capital Advisors LLC 13D and 13G filings for Aerpio Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-06-04
08:30 am
Purchase
2021-05-2713DAerpio Pharmaceuticals, Inc.
ARPO
Avoro Capital Advisors LLC300,000
9.500%
300,000increase
(New Position)
Filing